Leprosy Mailing List – October 17, 2013
Ref.: (LML) MB patients without clear treatment status and chronic ENL
From: José Augusto, Rio de Janeiro, Brazil
Dear Pieter,
We received some MB patients from other states without reliable information about their treatment history and if they received the full course of MDT. Most of these patients have still a high BI. These patients have maintained reactional episodes of ENL which are difficult to control.
Do you think these patients should be restated MDT to ensure a full course of MDT while we are trying to reduce these episodes of type II reaction? As reaction treatment usually thalidomide is given together with or without prednisone and pentoxifylline.
What is the advice of LML readers regarding this same situation (to restart a full course of MDT or not) in other countries?
Best regards,
Dr. José Augusto da Costa Nery
Ambulatório Souza Araújo
Laboratório de Hanseníase
Instituto Oswaldo Cruz - Fiocruz
Av. Brasil 4365, Manguinhos, Rio de Janeiro - RJ CEP 21040-360
Tel. (21)2562-1588
LML - S Deepak, B Naafs, S Noto and P Schreuder
LML blog link: http://leprosymailinglist.blogspot.it/
Contact: Dr Pieter Schreuder << editorlml@gmail.com
No comments:
Post a Comment